GRAMD1C and breast cancer: The results of the CCK-8 assay showed that the downregulation of INHBA inhibited the viability of BC cells, and the downregulation of NFKBIA promoted the viability of BC cells, while the downregulation of CD24, GRAMD1C and ACSS2 had no significant effect on cell viability (Fig. 7).